SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

SSY Group’s Sustained-Release Tofacitinib Tablets Approved

The tablets were approved for rheumatoid arthritis and related conditions.

GROUP

Related stories